by Kelli Brignac | Jan 12, 2026 | Haloscrips, Homepage, Population Health
For many companies, the transition from fully insured health benefits to a self-funded model offers a path to significant cost savings, greater transparency, and better plan control. However, the decision requires a structured approach to manage the risks and maximize...
by Jeff Yonker | Oct 8, 2025 | Haloscrips, Homepage, Population Health
Employer-sponsored health plans cover more than 150 million Americans. But amid exponentially rising costs, many employers are considering alternatives to the existing model. Enter the self-funded health plan. If you ask Google, you’ll see self-funded plans described...
by Jeff Yonker | Sep 26, 2025 | Haloscrips, Homepage, Population Health
Employer-sponsored health insurance is a staple of many employee benefits packages. These plans covered more than 150 million Americans in 2024, according to research by the Kaiser Family Foundation. Behind salaries, it’s usually one of any organization’s largest...
by Jeff Yonker | Jan 30, 2025 | Haloscrips, Population Health
As we step into 2025, the pharmacy profession finds itself navigating a rapidly changing landscape. Challenges like pharmacy deserts, workforce development, supply chain issues, and PBM reform are reshaping the industry. How will we respond? There is no...
by Jeff Yonker | Jan 17, 2025 | Haloscrips, Homepage, Population Health
A recent Wall Street Journal article, “Same Drug, 2200 Different Prices,” exposes a troubling issue: the extreme variability in pricing for generic medications. These bioequivalent drugs are manufactured by different companies but sold at widely differing...
by Jeff Yonker | Jan 13, 2025 | Haloscrips, Homepage, Population Health
Statins, including popular medications like Lipitor (atorvastatin) and Crestor (rosuvastatin), are among the most commonly prescribed drugs in the United States. Their ability to lower LDL cholesterol (the “bad” type) has undoubtedly saved countless lives by reducing...
